日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Long-term evolution of retinal atrophy after focal laser photocoagulation of telangiectatic capillaries: LyoMAC3 study

局部激光光凝治疗毛细血管扩张后视网膜萎缩的长期演变:LyoMAC3 研究

Vingerder, Damien; Sejournet, Lucas; Allignet, Benoit; Agard, Emilie; Mathis, Thibaud; Fenniri, Inès; Matagrin, Benjamin; Denis, Philippe; Burillon, Carole; Kodjikian, Laurent; Dot, Corinne

Continuous versus Intermittent Use of Tear Substitutes in Patients Treated with Anti-VEGF for Neovascular Age-Related Macular Degeneration: The TREDIA Study

抗 VEGF 治疗新生血管性年龄相关性黄斑变性患者持续使用人工泪液与间歇使用人工泪液的比较:TREDIA 研究

Torres-Villaros, Héloïse; Giocanti-Aurégan, Audrey; Doan, Serge; Agard, Emilie; Billant, Jérémy; Arbousoff, Nathalie; Matagrin, Benjamin; Fenniri, Inès; Dot, Corinne

SIRE: Short interval in real life Does intensive anti-VEGF treatment in the first year predict subsequent treatment burden in exudative age-related macular degeneration?

SIRE:现实生活中的短间隔 第一年进行强化抗 VEGF 治疗能否预测渗出性年龄相关性黄斑变性的后续治疗负担?

Matagrin, B; Fenniri, I; Chirpaz, N; Billant, J; Agard, E; Chudzinski, R; Burillon, C; Dot, C

VKORC1L1, an enzyme rescuing the vitamin K 2,3-epoxide reductase activity in some extrahepatic tissues during anticoagulation therapy

VKORC1L1是一种酶,可在抗凝治疗期间恢复某些肝外组织中的维生素K 2,3-环氧化物还原酶活性。

Hammed, Abdessalem; Matagrin, Benjamin; Spohn, Gabriele; Prouillac, Caroline; Benoit, Etienne; Lattard, Virginie

New insights into the catalytic mechanism of vitamin K epoxide reductase (VKORC1) - The catalytic properties of the major mutations of rVKORC1 explain the biological cost associated to mutations

维生素K环氧化物还原酶(VKORC1)催化机制的新见解——rVKORC1主要突变的催化特性解释了与突变相关的生物学代价

Matagrin, Benjamin; Hodroge, Ahmed; Montagut-Romans, Adrien; Andru, Julie; Fourel, Isabelle; Besse, Stéphane; Benoit, Etienne; Lattard, Virginie